RUA Life Sciences plc (RUA.L)
GBp 11.0
(0.0%)
GBp 11.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.38 Million | -1.17 Million | -2.36 Million | -1.42 Million | -431 Thousand | -429 Thousand |
| Net Income | -1.44 Million | -2 Million | -2.06 Million | -1.45 Million | -816 Thousand | -609 Thousand |
| Depreciation & Amortization | 364 Thousand | 358 Thousand | 313 Thousand | 272 Thousand | 194 Thousand | 159 Thousand |
| Deferred income taxes | -11 Thousand | 10 Thousand | -88 Thousand | -901 Thousand | -379 Thousand | 62 Thousand |
| Stock-based compensation | -35 Thousand | 102 Thousand | 145 Thousand | 128 Thousand | 91 Thousand | 42 Thousand |
| Change in working capital | 280 Thousand | 700 Thousand | -458 Thousand | -229 Thousand | 100 Thousand | -104 Thousand |
| Other non-cash items | 430 Thousand | -341 Thousand | -206 Thousand | 758 Thousand | 379 Thousand | 21 Thousand |
| Investing Cash Flow | -30 Thousand | -449 Thousand | -904 Thousand | -943 Thousand | -5000.00 | -133 Thousand |
| Investments in PPE | -55 Thousand | -449 Thousand | -904 Thousand | -620 Thousand | -5000.00 | -1000.00 |
| Acquisitions | 25 Thousand | - | - | -323 Thousand | - | -139 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 25 Thousand | -28 Thousand | -8000.00 | 9000.00 | 7000.00 | 7000.00 |
| Financing Cash Flow | 3.88 Million | 132 Thousand | -66 Thousand | 6.68 Million | - | 2.55 Million |
| Debt repayment | -86 Thousand | -132 Thousand | -66 Thousand | -222 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.97 Million | - | - | 6.46 Million | - | 2.55 Million |
| Other Financing Activities | 3.97 Million | 132 Thousand | -66 Thousand | 444 Thousand | - | 2.55 Million |
| Accounts receivables | -362 Thousand | 860 Thousand | 34 Thousand | -467 Thousand | -20 Thousand | -104 Thousand |
| Accounts payables | 104 Thousand | -203 Thousand | -453 Thousand | 231 Thousand | 120 Thousand | 31 Thousand |
| Inventory | -31 Thousand | 43 Thousand | -39 Thousand | 7000.00 | - | - |
| Other working capital | 569 Thousand | - | - | - | - | -31 Thousand |
| Cash at beginning of period | 1.48 Million | 2.96 Million | 6.29 Million | 1.97 Million | 2.41 Million | 422 Thousand |
| Cash at end of period | 3.93 Million | 1.48 Million | 2.96 Million | 6.29 Million | 1.97 Million | 2.41 Million |
| Capital Expenditure | -55 Thousand | -449 Thousand | -904 Thousand | -620 Thousand | -5000.00 | -1000.00 |
| Effect of forex changes on cash | -28 Thousand | 12 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 2.44 Million | -1.47 Million | -3.33 Million | 4.31 Million | -436 Thousand | 1.99 Million |
| Free Cash Flow | -1.43 Million | -1.62 Million | -3.26 Million | -2.04 Million | -436 Thousand | -430 Thousand |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.44 Million | -430 Thousand | -1.01 Million | -860 Thousand | -2 Million | -1.14 Million |
| Depreciation & Amortization | 364 Thousand | 179 Thousand | 185 Thousand | 184 Thousand | 358 Thousand | 174 Thousand |
| Deferred income taxes | -11 Thousand | -11 Thousand | -200 Thousand | 10 Thousand | 10 Thousand | 63 Thousand |
| Stock-based compensation | -35 Thousand | -96 Thousand | 61 Thousand | 56 Thousand | 102 Thousand | 46 Thousand |
| Change in working capital | 280 Thousand | -549 Thousand | 226 Thousand | 247 Thousand | 700 Thousand | 453 Thousand |
| Other non-cash items | 430 Thousand | 451 Thousand | -166 Thousand | -160 Thousand | -341 Thousand | -63 Thousand |
| Investing Cash Flow | -30 Thousand | -22 Thousand | -42 Thousand | -355 Thousand | -449 Thousand | -94 Thousand |
| Investments in PPE | -55 Thousand | -13 Thousand | -42 Thousand | -355 Thousand | -449 Thousand | -94 Thousand |
| Acquisitions | 25 Thousand | 25 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 25 Thousand | -9000.00 | -21 Thousand | -19 Thousand | -28 Thousand | -9000.00 |
| Financing Cash Flow | 3.88 Million | 3.91 Million | -30 Thousand | 22 Thousand | 132 Thousand | 110 Thousand |
| Debt repayment | -86 Thousand | -119 Thousand | -33 Thousand | -18 Thousand | -132 Thousand | -150 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.97 Million | 3.97 Million | - | - | - | - |
| Other Financing Activities | 3.97 Million | 3.91 Million | -30 Thousand | 22 Thousand | 132 Thousand | 110 Thousand |
| Accounts receivables | -362 Thousand | -576 Thousand | 214 Thousand | 421 Thousand | 860 Thousand | 439 Thousand |
| Accounts payables | 104 Thousand | 29 Thousand | 75 Thousand | -165 Thousand | -203 Thousand | -38 Thousand |
| Inventory | -31 Thousand | 27 Thousand | -58 Thousand | -13 Thousand | 43 Thousand | 56 Thousand |
| Other working capital | 569 Thousand | 574 Thousand | -5000.00 | 4000.00 | - | -4000.00 |
| Cash at beginning of period | 1.48 Million | 493 Thousand | 1.48 Million | 2.5 Million | 2.96 Million | 2.96 Million |
| Cash at end of period | 3.93 Million | 3.93 Million | 493 Thousand | 1.48 Million | 1.48 Million | 2.5 Million |
| Capital Expenditure | -55 Thousand | -13 Thousand | -42 Thousand | -355 Thousand | -449 Thousand | -94 Thousand |
| Effect of forex changes on cash | -28 Thousand | -13 Thousand | -15 Thousand | 12 Thousand | 12 Thousand | 2.96 Million |
| Net cash flow / Change in cash | 2.44 Million | 3.43 Million | -991 Thousand | -1.02 Million | -1.47 Million | -454 Thousand |
| Free Cash Flow | -1.43 Million | -458 Thousand | -946 Thousand | -1.05 Million | -1.62 Million | -564 Thousand |
GRXXF
EJT1
8113
3903
5938
7126